Lok AS - Search Results

1

Progression to cirrhosis is similar among all ages in nonalcoholic fatty liver disease, but liver-related events increase with age.

Miller MJ, Harding-Theobald E, DiBattista JV, Zhao Z, Wijarnpreecha K, Lok AS, Chen VL. Miller MJ, et al. Among authors: lok as. Hepatol Commun. 2023 Jun 2;7(6):e0148. doi: 10.1097/HC9.0000000000000148. eCollection 2023 Jun 1. Hepatol Commun. 2023. PMID: 37267221 Free PMC article.

2

High degree of conservation in the hepatitis B virus core gene during the immune tolerant phase in perinatally acquired chronic hepatitis B virus infection.

Bozkaya H, Akarca US, Ayola B, Lok AS. Bozkaya H, et al. Among authors: lok as. J Hepatol. 1997 Mar;26(3):508-16. doi: 10.1016/s0168-8278(97)80415-1. J Hepatol. 1997. PMID: 9075657

3

Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong.

Chan HL, Leung NW, Hussain M, Wong ML, Lok AS. Chan HL, et al. Among authors: lok as. Hepatology. 2000 Mar;31(3):763-8. doi: 10.1002/hep.510310330. Hepatology. 2000. PMID: 10706570 Free article.

4

Hepatitis B infection in patients with acute liver failure in the United States.

Teo EK, Ostapowicz G, Hussain M, Lee WM, Fontana RJ, Lok AS; US ALF Study Group (Acute Liver Failure). Teo EK, et al. Among authors: lok as. Hepatology. 2001 Apr;33(4):972-6. doi: 10.1053/jhep.2001.23065. Hepatology. 2001. PMID: 11283862 Free article.

5

NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States.

Marrero JA, Fontana RJ, Su GL, Conjeevaram HS, Emick DM, Lok AS. Marrero JA, et al. Among authors: lok as. Hepatology. 2002 Dec;36(6):1349-54. doi: 10.1053/jhep.2002.36939. Hepatology. 2002. PMID: 12447858 Free article.

6

Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients.

Marrero JA, Su GL, Wei W, Emick D, Conjeevaram HS, Fontana RJ, Lok AS. Marrero JA, et al. Among authors: lok as. Hepatology. 2003 May;37(5):1114-21. doi: 10.1053/jhep.2003.50195. Hepatology. 2003. PMID: 12717392

7

Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma.

Marrero JA, Fontana RJ, Fu S, Conjeevaram HS, Su GL, Lok AS. Marrero JA, et al. Among authors: lok as. J Hepatol. 2005 Feb;42(2):218-24. doi: 10.1016/j.jhep.2004.10.005. J Hepatol. 2005. PMID: 15664247

8

GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma.

Marrero JA, Romano PR, Nikolaeva O, Steel L, Mehta A, Fimmel CJ, Comunale MA, D'Amelio A, Lok AS, Block TM. Marrero JA, et al. Among authors: lok as. J Hepatol. 2005 Dec;43(6):1007-12. doi: 10.1016/j.jhep.2005.05.028. Epub 2005 Jun 28. J Hepatol. 2005. PMID: 16137783

9

Cognitive function in hepatitis C patients with advanced fibrosis enrolled in the HALT-C trial.

Fontana RJ, Bieliauskas LA, Back-Madruga C, Lindsay KL, Kronfol Z, Lok AS, Padmanabhan L; HALT-C Trial Group. Fontana RJ, et al. Among authors: lok as. J Hepatol. 2005 Oct;43(4):614-22. doi: 10.1016/j.jhep.2005.04.006. J Hepatol. 2005. PMID: 16237784 Clinical Trial.

10

Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial.

Lok AS, Everhart JE, Chung RT, Kim HY, Everson GT, Hoefs JC, Greenson JK, Sterling RK, Lindsay KL, Lee WM, Di Bisceglie AM, Bonkovsky HL, Ghany MG, Morishima C; HALT-C Trial Group. Lok AS, et al. Hepatology. 2009 Jun;49(6):1828-37. doi: 10.1002/hep.22865. Hepatology. 2009. PMID: 19291787 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

634 results

Search Page

Filters